Contemporary Oncology (Jan 2024)
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure
Abstract
No abstracts available.Keywords
Contemporary Oncology (Jan 2024)